Literature DB >> 23592390

Recurrence of subsquamous dysplasia and carcinoma after successful endoscopic and radiofrequency ablation therapy for dysplastic Barrett's esophagus.

J K Lee1, R G Cameron, K F Binmoeller, J N Shah, A Shergill, R Garcia-Kennedy, Y M Bhat.   

Abstract

Barrett's esophagus with dysplasia is commonly treated with radiofrequency ablation (RFA). Despite its effectiveness, a concern of any ablative technique is the development of subsquamous intestinal metaplasia, which could have potential for future neoplastic progression. To date, 34 cases of subsquamous neoplasia have been described in the literature after various ablation therapies. However, only three cases of subsquamous neoplasia have been reported after successful RFA treatment of dysplastic Barrett's esophagus. In this case series, we report on four additional cases of subsquamous neoplasia detected after successful endoscopic resection and RFA for neoplastic and dysplastic Barrett's esophagus. All four patients were treated successfully with endoscopic resection of their recurrent subsquamous neoplastic and dysplastic lesions. This case series highlights the need for continued surveillance following successful treatment of dysplastic Barrett's esophagus with RFA. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2013        PMID: 23592390     DOI: 10.1055/s-0032-1326419

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  12 in total

Review 1.  Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists.

Authors:  Bita V Naini; Rhonda F Souza; Robert D Odze
Journal:  Am J Surg Pathol       Date:  2016-05       Impact factor: 6.394

2.  Development of Evidence-Based Surveillance Intervals After Radiofrequency Ablation of Barrett's Esophagus.

Authors:  Cary C Cotton; Rehan Haidry; Aaron P Thrift; Laurence Lovat; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2018-04-13       Impact factor: 22.682

Review 3.  Post-ablation surveillance in Barrett's esophagus: A review of the literature.

Authors:  Matthew W Stier; Vani J Konda; John Hart; Irving Waxman
Journal:  World J Gastroenterol       Date:  2016-05-07       Impact factor: 5.742

Review 4.  Natural History of the Post-ablation Esophagus.

Authors:  Craig C Reed; Nicholas J Shaheen
Journal:  Dig Dis Sci       Date:  2018-08       Impact factor: 3.199

5.  Recurrent intestinal metaplasia after radiofrequency ablation for Barrett's esophagus: endoscopic findings and anatomic location.

Authors:  Cary C Cotton; W Asher Wolf; Sarina Pasricha; Nan Li; Ryan D Madanick; Melissa B Spacek; Kathleen Ferrell; Evan S Dellon; Nicholas J Shaheen
Journal:  Gastrointest Endosc       Date:  2015-03-24       Impact factor: 9.427

Review 6.  Durability of Endoscopic Treatment for Dysplastic Barrett's Esophagus.

Authors:  Craig C Reed; Nicholas J Shaheen
Journal:  Curr Treat Options Gastroenterol       Date:  2019-06

7.  Management of Barrett Esophagus Following Radiofrequency Ablation.

Authors:  Craig C Reed; Nicholas J Shaheen
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-07

8.  ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus.

Authors:  Nicholas J Shaheen; Gary W Falk; Prasad G Iyer; Lauren B Gerson
Journal:  Am J Gastroenterol       Date:  2015-11-03       Impact factor: 10.864

Review 9.  Update on ablation for Barrett's esophagus.

Authors:  Gary W Falk
Journal:  Curr Gastroenterol Rep       Date:  2014-01

Review 10.  Outcomes of Radiofrequency Ablation for Dysplastic Barrett's Esophagus: A Comprehensive Review.

Authors:  Carmelo Luigiano; Giuseppe Iabichino; Leonardo Henry Eusebi; Monica Arena; Pierluigi Consolo; Carmela Morace; Enrico Opocher; Benedetto Mangiavillano
Journal:  Gastroenterol Res Pract       Date:  2016-12-14       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.